Chemoinformaics analysis of 1,8-Heptadecadiene-4,6-diyne-3,10-diol
Molecular Weight | 260.377 | nRot | 8 |
Heavy Atom Molecular Weight | 236.185 | nRig | 16 |
Exact Molecular Weight | 260.178 | nRing | 0 |
Solubility: LogS | -3.534 | nHRing | 0 |
Solubility: LogP | 3.148 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 45.997 |
nHD | 2 | BPOL | 24.077 |
QED | 0.794 |
Synth | 3.159 |
Natural Product Likeliness | 0.631 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.234 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.588 |
MDCK | 0.0000613 |
BBB | 0.871 |
PPB | 0.750542 |
VDSS | 2.578 |
FU | 0.131946 |
CYP1A2-inh | 0.105 |
CYP1A2-sub | 0.87 |
CYP2c19-inh | 0.18 |
CYP2c19-sub | 0.935 |
CYP2c9-inh | 0.026 |
CYP2c9-sub | 0.444 |
CYP2d6-inh | 0.97 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.125 |
CYP3a4-sub | 0.512 |
CL | 12.252 |
T12 | 0.632 |
hERG | 0.435 |
Ames | 0.016 |
ROA | 0.805 |
SkinSen | 0.106 |
Carcinogencity | 0.245 |
EI | 0.025 |
Respiratory | 0.633 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.832263 |